Form 4: Merck & Co. Executive Sells Shares
Insider Transaction (Form 4)
Richard R. Deluca, EVP&Pres, Merck Animal Heallth of Merck & Co., Inc., sold 6,050 shares of common stock on August 6, 2026.
Summary
- Open-market sale: disposed of 805 Common Stock at $131.02 ($105,472) on August 6, 2026; holds 160,732 after (Direct).
- Open-market sale: disposed of 4,945 Common Stock at $130.23 ($643,993) on August 6, 2026; holds 155,787 after (Direct).
- Open-market sale: disposed of 300 Common Stock at $131.02 ($39,307) on August 6, 2026; holds 155,487 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $788,773 of stock on the open market.
Insider Transactions
Richard R. Deluca — Officer (EVP&Pres, Merck Animal Heallth)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Open-market sale | Common Stock | 805 | $131 | $105.5K | 160,732.07 |
| 2026-08-06 | Open-market sale | Common Stock | 4,945 | $130 | $644.0K | 155,787.07 |
| 2026-08-06 | Open-market sale | Common Stock | 300 | $131 | $39.3K | 155,487.07 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Open-market sale (805 shares) |
| 2026-08-06 | Open-market sale (4,945 shares) |
| 2026-08-06 | Open-market sale (300 shares) |
Keywords
insider transaction, Form 4, MRK, Merck & Co., Inc., bearish, Richard R. Deluca
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.